ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 2.150
+0.650 (43.33%)
At close: Aug 28, 2026
ME Therapeutics Holdings Balance Sheet
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Cash & Equivalents | 0.48 | 1.35 | 1.5 | 0.65 | 0.08 | 0.07 |
Short-Term Investments | 0.06 | 0.06 | - | - | - | - |
Cash & Short-Term Investments | 0.54 | 1.4 | 1.5 | 0.65 | 0.08 | 0.07 |
Cash Growth | -68.61% | -6.27% | 131.28% | 736.35% | 5.91% | 47.00% |
Other Receivables | 0.05 | 0.07 | 0.02 | 0.01 | 0.02 | 0 |
Receivables | 0.05 | 0.07 | 0.02 | 0.01 | 0.02 | 0 |
Prepaid Expenses | 0.01 | 0.03 | 0.03 | 0.02 | 0 | - |
Total Current Assets | 0.59 | 1.5 | 1.54 | 0.67 | 0.1 | 0.08 |
Property, Plant & Equipment | 0.2 | 0.25 | 0 | 0 | 0 | 0 |
Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
Other Long-Term Assets | 0.01 | 0.01 | - | - | - | - |
Total Assets | 0.8 | 1.76 | 1.54 | 0.67 | 0.1 | 0.08 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Accounts Payable | 0.09 | 0.16 | 0.05 | 0.11 | 0.02 | 0.03 |
Accrued Expenses | 0.03 | 0.01 | 0.02 | - | - | - |
Short-Term Debt | - | - | - | - | 0.13 | - |
Current Portion of Long-Term Debt | - | - | - | 0.04 | - | - |
Current Portion of Leases | 0.03 | 0.06 | - | - | - | - |
Other Current Liabilities | - | 0.01 | - | 0 | 0.02 | 0.01 |
Total Current Liabilities | 0.15 | 0.25 | 0.06 | 0.15 | 0.17 | 0.03 |
Long-Term Debt | - | - | - | - | 0.06 | 0.06 |
Long-Term Leases | - | 0.01 | - | - | - | - |
Total Liabilities | 0.15 | 0.26 | 0.06 | 0.15 | 0.23 | 0.09 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Common Stock | 8.92 | 8.59 | 6.11 | 4.52 | 0.51 | 0.51 |
Retained Earnings | -9.9 | -9.73 | -8.54 | -7.24 | -0.72 | -0.57 |
Comprehensive Income & Other | 1.62 | 2.64 | 3.9 | 3.24 | 0.08 | 0.04 |
Shareholders' Equity | 0.65 | 1.5 | 1.48 | 0.52 | -0.13 | -0.02 |
Total Liabilities & Equity | 0.8 | 1.76 | 1.54 | 0.67 | 0.1 | 0.08 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Total Debt | 0.03 | 0.07 | - | 0.04 | 0.19 | 0.06 |
Net Cash (Debt) | 0.51 | 1.33 | 1.5 | 0.61 | -0.12 | 0.01 |
Net Cash Growth | -68.62% | -11.06% | 146.52% | - | - | 34.62% |
Net Cash Per Share | 0.02 | 0.05 | 0.06 | 0.04 | -0.01 | 0.00 |
Filing Date Shares Outstanding | 30.05 | 30.05 | 25.19 | 23.56 | 6.08 | 6.08 |
Total Common Shares Outstanding | 30.05 | 29.59 | 25.19 | 23.56 | 6.08 | 6.08 |
Working Capital | 0.44 | 1.26 | 1.48 | 0.52 | -0.07 | 0.04 |
Book Value Per Share | 0.02 | 0.05 | 0.06 | 0.02 | -0.02 | -0.00 |
Tangible Book Value | 0.65 | 1.5 | 1.48 | 0.52 | -0.13 | -0.02 |
Tangible Book Value Per Share | 0.02 | 0.05 | 0.06 | 0.02 | -0.02 | -0.00 |
Machinery | 0.22 | 0.19 | 0 | 0 | 0 | 0 |
Leasehold Improvements | 0.03 | 0.03 | - | - | - | - |